Valeant Pharmaceuticals International VP of Finance Salary | Comparably
Valeant Pharmaceuticals International develops and markets medications used in the fields of neurology, dermatology and infectious diseases. read more
EMPLOYEE
PARTICIPANTS
8
TOTAL
RATINGS
107

Valeant Pharmaceuticals International VP of Finance Salary

The average Valeant Pharmaceuticals International VP of Finance earns an estimated $149,524 annually. Valeant Pharmaceuticals International's VP of Finance compensation is $57,006 less than the US average for a VP of Finance.

The Finance Department at Valeant Pharmaceuticals International earns $2,225 more on average than the Marketing Department.

Last updated 2 years ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$149,524
Average Compensation
$149,524
avg. base

VP of Finance Salaries at Valeant Pharmaceuticals International

VPs of Finance earn $33,330 more than Accounting Managers.

Accounting Manager
$116k*
Senior Accountant
$92k*
Business Analyst
$91k*
Financial Analyst
$84k*
Accountant
$61k*
* estimated salary

Compensation at Valeant Pharmaceuticals International by Department

The Finance Department averages $2,225 more than the Marketing Department, and $1,289 less than the Sales Department

Sales
$95,974 Avg. total comp.
+$1k
Finance
$94,685 Avg. total comp.
Marketing
$92,460 Avg. total comp.
-$2k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to Valeant Pharmaceuticals International reported making $188,034, while the average male VP of Finance at similar sized companies reported making $216,094.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to Valeant Pharmaceuticals International reported making $207,596, while the average Hispanic or Latino VP of Finance at similar sized companies reported making $170,500.

How VPs of Finance at Valeant Pharmaceuticals International Rate Their Compensation

The majority of VPs of Finance at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of VPs of Finance at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International

×
Rate your company